Skip to main content
logo
ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
78.51
-2.60 (-3.21%)
At close: May 29, 2026, 4:00 PM EDT
78.55
+0.04 (0.05%)
After-hours: May 29, 2026, 5:40 PM EDT

ANI Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,6651,7751,1671,129704776
Market Cap Growth
27.31%52.16%3.40%60.35%-9.25%116.16%
Enterprise Value
1,9692,0981,6651,218966.94987.41
Last Close Price
78.5178.9455.2855.1440.2346.08
PE Ratio
20.1223.78-64.87--
Forward PE
8.5610.0310.7214.0414.7912.86
PEG Ratio
-0.400.400.401.111.02
PS Ratio
1.802.011.902.322.223.59
PB Ratio
2.983.282.892.612.242.32
P/TBV Ratio
2.923.102.652.322.091.73
P/FCF Ratio
8.71-24.4210.25-1013.74
P/OCF Ratio
7.98-18.239.49-233.45
EV/Sales Ratio
2.132.372.712.503.064.57
EV/EBITDA Ratio
9.9818.8824.3711.4139.68132.38
EV/EBIT Ratio
18.2418.882850.4025.93--
EV/FCF Ratio
10.30-34.8411.06-1290.74
Debt / Equity Ratio
1.091.141.460.620.850.80
Debt / EBITDA Ratio
4.965.559.142.6811.7638.52
Debt / FCF Ratio
--13.062.60-375.62
Net Debt / Equity Ratio
0.510.601.170.150.760.56
Net Debt / EBITDA Ratio
2.322.906.920.619.7825.08
Net Debt / FCF Ratio
--9.900.59-5.95244.51
Asset Turnover
0.650.650.560.580.410.35
Inventory Turnover
2.532.442.021.681.481.41
Quick Ratio
2.432.071.932.632.152.61
Current Ratio
3.122.712.723.573.463.68
Return on Equity (ROE)
16.71%16.16%-4.18%4.72%-13.74%-15.37%
Return on Assets (ROA)
6.87%6.67%0.04%5.33%-3.52%-4.91%
Return on Invested Capital (ROIC)
10.57%9.41%0.06%7.19%-4.26%-5.82%
Return on Capital Employed (ROCE)
10.56%9.86%0.06%6.62%-5.25%-7.46%
Earnings Yield
5.04%4.21%-1.54%--
FCF Yield
11.48%0.00%4.09%9.76%-0.10%
Buyback Yield / Dilution
-11.10%-9.89%-6.18%-11.89%-29.77%-4.73%
Total Shareholder Return
-11.10%-9.89%-6.18%-11.89%-29.77%-4.73%
SEC Filings: 10-K · 10-Q